In comparison, the non‐third‐generation EGFR‐TKIs group reported liver damage (2 patients, 5.4%), kidney damage (1 patient, 2.7%), and bone marrow suppression (3 patients, 8.1%). Here, EGFR is linked to Nephropathy.